Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Limited [Glenmark] is an India-based growing pharmaceutical company headquartered at Mumbai [formerly, Bombay]. Incorporated in 1977, the Company is focused on the manufacture and marketing of formulation products and active pharmaceutical ingredients [API] in India as well as globally and enjoys a diversified and growing presence in regulated and developing international markets. Over the past five years, the Company has also catalysed its growth through investment in dedicated research and development including cutting-edge New Chemical Entity [NCE] research.

Contact Details: 750 Corporate Drive Mahwah New Jersey 07430 United States of America Tel: [1 201] 684 8000 Fax: [1 201] 831 0080 Email: api_usa@glenmarkpharma.com WWW: www.glenmarkpharma.com/

Loading...

Recent Publications by Glenmark Pharmaceuticals Ltd:
Lornoxicam efficacy in acute pain (LEAP) trial. Parenteral non-steroidal anti-inflammatory drugs (NSAIDs) are useful...	8th May, 2009	Glenmark Pharmaceuticals Ltd, Mumbai.	J Indian Med Assoc. 2008 Dec;106(12):811-3.
Evaluation of fixed dose combination (FDC) of telmisartan+ramipril usage in patients with micro-albuminuria and persistent hypertension: A TRIUMPH study. Micro-albuminuria is a marker for declining kidney function and predicts...	11th September, 2008	Medical Services Department, Glenmark Pharmaceuticals Ltd, Mumbai.	J Indian Med Assoc. 2008 Mar;106(3):191-4, 196.
An open prospective study on postmarketing evaluation of the efficacy and tolerability of diacerein in osteo-arthritis of the knee (DOK). According to World Health Organisation osteo-arthritis is the second...	3rd September, 2008	Glenmark Pharmaceuticals Limited, Mumbai.	J Indian Med Assoc. 2008 Jan;106(1):54-6, 58.
Comparative assessment of the bioavailability, efficacy and safety of a modified-release (MR) carbonyl iron tablet and oral conventional iron preparation in adult Indian patients with nutritional iron deficiency anaemia. The objective of the study is to evaluate the bioavailability, efficacy...	16th November, 2005	Glenmark Pharmaceuticals Ltd, Mumbai.	J Indian Med Assoc. 2005 Jun;103(6):338-42.
A pilot study for evaluation of the efficacy and safety of telmisartan in reducing microalbuminuria in hypertensive patients with type 2 diabetes mellitus. To evaluate efficacy and tolerability of telmisartan, an angiotensim II...	18th October, 2005	Glenmark Pharmaceuticals Ltd, Mumbai 400026.	J Indian Med Assoc. 2005 Mar;103(3):187-91.
→View more Glenmark Pharmaceuticals Ltd research publications.

Press Releases on Glenmark Pharmaceuticals Ltd:
Glenmark's Novel Molecule for Diabetes, Melogliptin to Enter Phase III Trials	24th June, 2009	Glenmark Pharmaceuticals Ltd.	Release Highlights - Melogliptin continues to demonstrate potential to be the best-in-class in achieving glycemic control with low incidence of hypoglycemia and neutral effect on
Glenmark Expects Launch of Crofelemer in ROW Countries(Developing Economies) by 2010 - Potential First-in-Class for HIV-Associated Diarrhea: Molecule Currently in Phase 3 Trials, Granted Fast Track Designation by US-FDA	22nd December, 2008	Glenmark Pharmaceuticals Ltd.	MUMBAI, December 22 /PRNewswire-FirstCall/ -- - Potential First-in-Class Anti-Secretory Anti-Diarrheal Agent for Multiple Indications Including HIV-Associated Diarrhea - Glenmark has

BioNews Results for Glenmark Pharmaceuticals Ltd:
Glenmark Generics settles litigation with Medicis Pharma	Yahoo! India:  Nov 16 2009 6:14AM Matching: glenmark pharmaceuticals
Glenmark Pharmaceuticals wins USFDA approval for Ciclopirox cream	Stockwatch.in:  Nov 14 2009 10:32PM Matching: glenmark pharmaceuticals
Glenmark Pharma gets USFDA nod for Ciclopirox cream	MyIris:  Nov 14 2009 4:22AM Matching: glenmark pharmaceuticals
Warning Letters 2009	U.S. Food and Drug Administration:  Nov 14 2009 2:40AM Matching: glenmark pharmaceuticals
Glenmark's consolidated revenue increases 5% in Q2	Bio Spectrum Asia:  Nov 2 2009 8:47AM Matching: glenmark pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution	→View more Glenmark Pharmaceuticals Ltd news.

Glenmark Pharmaceuticals Ltd Clinical Trials:
A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma

Glenmark Pharmaceuticals Ltd Patents:
US Patent No.	Title
7563900	Process for the preparation N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methane sulfonamido-dibenzo[b,d]furan-1-carboxamide
7205323	Dipeptidyl peptidase IV inhibitors pharmaceutical compositions containing them, and process for their preparation
7223789	Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
7230002	Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
7238725	Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
→View more Glenmark Pharmaceuticals Ltd patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 990 times since April 2007, the link to the organisation's website has been followed 77 times

Recent Search Terms used to find this page: Recent patent from glenmark pharma | glenmark india ltd | formulations-product list glenmark india mumbai | Formulations product list glenmark mumbai | buildings view of glenmark generics ltd mumbai | glenmark pharmaceuticals ltd | diacerein glenmark india approval | research publications of glenmark pharmaceuticals ltd | research publications of glenmark pharmaceuticals ltd | glenmark pharma | .

Search for more companies in Mahwah

Search for more companies in New Jersey

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Glenmark Pharmaceuticals Ltd